HDAC6 is an important target for neuroprotection and neuroregeneration in traumatic brain injury, stroke and neurodegenerative disorders 11-14 and HDAC inhibitors reduce the cytotoxic effects of anti-tumor agents in normal cells 53, 54. This evidence concerns the gene HDAC6 and neoplasm.